The Human Tumor Cloning Assay: An In Vitro Assay for Antitumor Activity in Solid Tumors

  • John D. Cowan
  • Daniel D. Von Hoff
Part of the Cancer Treatment and Research book series (CTAR, volume 7)

Abstract

It is desirable to develop an in vitro system to predict the activity of antineoplastic agents in man, much as bacterial culture and sensitivity techniques are used in the treatment of infectious disease. Such a test would allow the rapid screening of potential anticancer agents for activity and might allow the selection of appropriate chemotherapy for an individual patient’s tumor.

Keywords

Human Tumor Soft Agar Human Tumor Cell Drug Sensitivity Tumor Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cline M: In Vitro test systems for anticancer drugs. N Engl J Med 280:955, 1969.Google Scholar
  2. 2.
    Eagle H, Foley GE: Cytotoxicity in human cell cultures as a primary screen for the detection of antitumor agents. Cancer Res 18: 1017–1025, 1958.PubMedGoogle Scholar
  3. 3.
    Dendy PP, Bozman G, Wheeler TK: In Vitro screening test for malignant human tumors before chemotherapy. Lancet 2: 68–72, 1970.CrossRefGoogle Scholar
  4. 4.
    Lickiss JN, Cane KA, Baikie AG: In Vitro drug selection in antineoplastic chemotherapy. Eur J Cancer 10: 809–814, 1974.PubMedCrossRefGoogle Scholar
  5. 5.
    Wright JC, Cobb JP, Gumport SL, Safad D, Walker DG, Golomb FM: Further investigation of the relation between the clinical and tissue culture response to chemotherapeutic agents on human cancer. Cancer 15: 284–293, 1962.PubMedCrossRefGoogle Scholar
  6. 6.
    Hurley J, Yount L: Selection of anticancer drug for palliation using tissue culture sensitivity studies. Am J Surgery 109: 39–42, 1965.CrossRefGoogle Scholar
  7. 7.
    Holmes HL, Little JM: Tissue culture microtest for predicting response of human cancer to chemotherapy. Lancet 2: 985–987, 1974.PubMedCrossRefGoogle Scholar
  8. 8.
    Durkin WJ, Ghanta VK, Balch CM, Davis DW, Hiramoto RN: A methodological approach to the prediction of anticancer drug effect in humans. Cancer Res 39: 402–407, 1979.PubMedGoogle Scholar
  9. 9.
    Weisenthal LM, Marsden J: A novel dye exclusion assay for predicting response to cancer chemotherapy. Proc Am Assoc Cancer Res and ASCO 22: 155, 1981.Google Scholar
  10. 10.
    DiPaola JA: Analysis of an individual chemotherapy assay system. Natl Cancer Inst Monogr 34: 240–245, 1971.Google Scholar
  11. 11.
    Kondo T: Prediction of response of tumor and host to cancer chemotherapy. Natl Cancer Inst Monogr 34: 251–256, 1971.PubMedGoogle Scholar
  12. 12.
    McGuire WL: Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5: 428–433, 1978.PubMedGoogle Scholar
  13. 13.
    Smyth JF, Robins AB, Leese CL: The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukemia. Eur J Cancer 12: 567–573, 1976.PubMedCrossRefGoogle Scholar
  14. 14.
    Kessel D: Relevance of In Vitro tests for predicting responsiveness to antitumor agents. Natl Cancer Inst Monogr 34: 138–145, 1971.PubMedGoogle Scholar
  15. 15.
    Livingston RB: Depression of thymidine labeling index In Vitro predicts effects of chemotherapy in patients. Proc Am Assoc Cancer Res and ASCO 20: 317, 1979.Google Scholar
  16. 16.
    McDonald GO, Mclver JM, Llamas AJ, Sky–Peck HH: Tumor cytotoxicity: quantitative changes in DNA synthesis as an indicator. Arch Surg 92: 541–547, 1966.PubMedGoogle Scholar
  17. 17.
    Cline M: Prediction of in vivo cytotoxicity of chemotherapeutic agents by their effect on malignant leukocytes In Vitro. Blood 30: 176–187, 1967.PubMedGoogle Scholar
  18. 18.
    Roper P, Drewinko B: Comparison of In Vitro methods to determine drug induced cell lethality. Cancer Res 36: 2182–2188, 1976.PubMedGoogle Scholar
  19. 19.
    Fjelde A: Human tumor cells in tissue culture. Cancer 8: 845–851, 1955.PubMedCrossRefGoogle Scholar
  20. 20.
    Leibovitz A, Stinson JC, McCombs WB III, McCoy CE, Mazur KC, Mabry ND: Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562–4569, 1976.PubMedGoogle Scholar
  21. 21.
    Pickard RG, Cobb LM, Steel GG: The growth kinetics of xenografts of human colorectal tumors in immune deprived mice. Br J Cancer 31: 36–45, 1975.PubMedCrossRefGoogle Scholar
  22. 22.
    Smith IE, Courtenay VD, Gordon MY: A colony forming assay for human tumor xenografts using agar in diffusion chambers. Br J Cancer 34: 476–484, 1976.PubMedCrossRefGoogle Scholar
  23. 23.
    Lamerton LF, Steel GG: Growth kinetics of human large bowel cancer growing in immune deprived mice and some chemotherapeutic observations. Cancer 36: 2431–2436, 1975.PubMedCrossRefGoogle Scholar
  24. 24.
    Berry RJ, Laing AH, Wells J: Fresh explant culture of human tumors In Vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer 31: 218–227, 1975.PubMedCrossRefGoogle Scholar
  25. 25.
    Fuskova T, Fuska J, Ivanitskaya LP, Makwkho LV: Different sensitivity to antibiotics of the established intermittent In Vitro - in vivo tumor cell line in comparison with primary culture. Neoplasma 24: 239–242, 1977.PubMedGoogle Scholar
  26. 26.
    Steel GG. Cell kinetics and cell survival. In: Medical oncology - Medical aspects of malignant disease, Bagshawe KD (ed). Oxford: Blackwell, 1975, pp 49–66.Google Scholar
  27. 27.
    Pike BL, Robinson WA: Human bone marrow colony growth in agargel. J Cell Physiol 76: 77–81, 1970.PubMedCrossRefGoogle Scholar
  28. 28.
    Tepperman AJ, Curtin J, McCulloch EA: Erythropoietic colonies in culture of human marrow. Blood 44: 659–669, 1974.PubMedGoogle Scholar
  29. 29.
    Hewitt HB, Wilson CW: A survival curve for mammalian leukemic cells irradiated In Vitro. Br J Cancer 13: 69–75, 1959.PubMedCrossRefGoogle Scholar
  30. 30.
    Hill RP, Bush RS: A lung colony assay to determine the radiosensitivity of the cells of a solid tumor. Int J Radiat Biol 15: 435–44, 1969.CrossRefGoogle Scholar
  31. 31.
    Bruce WR, Meeker BE, Valeriote FA: Comparison of the sensitivity of normal and transplanted lymphoma colony forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37: 233–45, 1966.PubMedGoogle Scholar
  32. 32.
    Wilcox WS, Griswold DP, Laster WR, Schabel FM, Skipper HF: Experimental evaluation of potential anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. Cancer Chemother Rep 47: 27–39, 1965.PubMedGoogle Scholar
  33. 33.
    Brown CH, Carbone PP: In Vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst 46: 989–1000, 1971.PubMedGoogle Scholar
  34. 34.
    Hermens AF, Barendsen GW: Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after x-irradiation. Eur J Cancer 5: 173–189, 1969.PubMedCrossRefGoogle Scholar
  35. 35.
    Park CH, Bergsagel DE, McCulloch EA: Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 46: 411–422, 1971.PubMedGoogle Scholar
  36. 36.
    Ogawa W, Bergsagel DE, McCulloch EA. Chemotherapy of mouse myeloma: qualitative cell cultures predictive of response in vivo. Blood 41: 7–15, 1973.PubMedGoogle Scholar
  37. 37.
    McAllister RM, Reed G: Colony growth in agar of cells from neoplastic and nonneoplastic tissues of children. Pediat Res 2: 356–360, 1968.PubMedCrossRefGoogle Scholar
  38. 38.
    Altman AJ, Crussi FG, Rierden WJ, Baehner RL: Growth of rhabdomyosarcoma colonies from pleural fluids. Cancer Res 35: 1809–1812, 1975.Google Scholar
  39. 39.
    Hamburger AW, Salmon SE, Kim MB, Trent JM, Soehnlen BJ, Alberts DS, Schmidt HJ: Direct cloning of human ovarian carcinoma cell in agar. Cancer Res 38: 3438–3444, 1978.PubMedGoogle Scholar
  40. 40.
    Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197: 461–463, 1977.PubMedCrossRefGoogle Scholar
  41. 41.
    Hamburger A, Salmon SE: Primary bioassay of human myeloma stem cells. J Clin Invest 60: 846–854, 1977.PubMedCrossRefGoogle Scholar
  42. 42.
    Costachel O, Fadei L, Badea E: Tumor cell suspension culture on non–adhesive substratum. Z Krebsforsch 72: 24–31, 1969.PubMedCrossRefGoogle Scholar
  43. 43.
    Salmon SE, Buick RM. Preparation of permanent slides of soft agar colonies of hematopoietic and tumor stem cells. Cancer Res 39: 1133–1136, 1979.PubMedGoogle Scholar
  44. 44.
    Von Hoff DD, Harris GJ, Johnson G, Glaubiger D: Initial experience with the human tumor stem cell assay system: potentials and problems. In: Human tumor cloning, Salmon SE (ed). New York: Alan Liss, 1980, pp 113–124.Google Scholar
  45. 45.
    Harris GJ, Zeagler J, Hode KA, Casper J, Von Hoff DD: Ultrastructural analysis of colonies growing in a human tumor cloning system. Cancer (in press).Google Scholar
  46. 46.
    Trent JM: Cytogenetic analysis of human tumor cells cloned in agar. In: Cloning of human tumor stem cells, Salmon SE (ed). New York: Alan Liss, 1980, pp 165–179.Google Scholar
  47. 47.
    Buick RN, Stanisic TH, Fry SE, Salmon SE, Trent JM, Krasovich P: Development of an agar/methyl cellulose clonogenic assay for progenitor cells in transitional cell carcinoma of the bladder. Cancer Res 39: 5051–5056, 1979.PubMedGoogle Scholar
  48. 48.
    Brodeur GM, Sekhon GS, Goldstein MN: Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256–2263, 1977.PubMedCrossRefGoogle Scholar
  49. 49.
    Von Hoff DD: New leads from the laboratory for treating testicular cancer. In: Therapeutic progress in ovarian cancer, testicular cancer and sarcomas, Van Oosterom (ed.). The Hague: Martinus Nijhoff, 1980, p225–234.Google Scholar
  50. 50.
    Leibovitz A: In: Human tumor cells In Vitro, Fogh J (ed). New York: Plenum, 1975, pp 23–50.Google Scholar
  51. 51.
    Mavligit GM, Hersh EM, McBride CM: Lymphocyte blastogenic responses to autochthonous viable and nonviable human tumor cells. J Natl Cancer Inst 51: 337–343, 1973.PubMedGoogle Scholar
  52. 52.
    Mattern J, Kaufmann M, Wayss K, Volm M: Studies on the drug sensitivity of short term cultured tumor cell suspensions. In: Human tumors in short term culture, Dendy PP (ed). New York: Academic Press, 1976, pp 301–310.Google Scholar
  53. 53.
    Pretlow TG, Jones CM, Pretlow TP: Separation of tumor cells by density gradient centrifugation: recent work with human tumors and discussion of the kind of quantitation needed in cell separation experiments. Biophys Chem 5: 99–106, 1976.PubMedCrossRefGoogle Scholar
  54. 54.
    Rockwell S: In vivoIn Vitro tumor systems: new models for studying the response of tumors to therapy. Lab Anim Sci 27:831–851, 1977.Google Scholar
  55. 55.
    Daniels A, Daniels J, Luck EE: Agarose matrix and enzyme disaggregation improve efficiency of the soft agar chemosensitivity test. Proc Am Assoc Cancer Res and ASCO 22: 155, 1981.Google Scholar
  56. 56.
    VanWezel AL, VanHemert PA, Parisius W, Cucakovich NB, Macmorine HG: Improved cell dispersal method by low temperature incubation of tissue in trypsincitrate solution. Appl Microbiol 24: 506–507, 1972.Google Scholar
  57. 57.
    Pretlow TG, Brattain MG, Kreisberg JI: Separation and characterization of epithelial cells from prostates and prostatic carcinoma: a review. Cancer Treat Rep 61: 153–156, 1977.PubMedGoogle Scholar
  58. 58.
    Brattain MG, Pretlow TP, Pretlow TG: Cell fractionation of large bowel cancer. Cancer 40: 2479–2480, 1977.PubMedCrossRefGoogle Scholar
  59. 59.
    Kimball PM, Brattain MG, Pitts AM: A soft agar procedure measuring growth of human colonic carcinoma. Br J Cancer 37: 1015–1019, 1978.PubMedCrossRefGoogle Scholar
  60. 60.
    Slocum HK, Pavelic ZP, Rustum YM, Creaven PJ, Karakousis C, Takita H, Greco WR: Characterization of cells obtained by medical and enzymatic means from human melanoma and sarcoma and lung tumors. Cancer Res 41: 1428–1434, 1981.PubMedGoogle Scholar
  61. 61.
    Freshney RI: Tumor cells disaggregated in collagenase. Lancet 2: 488–489, 1972.PubMedCrossRefGoogle Scholar
  62. 62.
    Twentyman PR: Sensitivity to 1-3-bis (2-chlorethyl)-1-nitrosourea and l-(2-chloroethyl)-3-(4-methylcyclohexyl)-l-nitrosourea of the EmTG tumor in vivo as determined by both tumor volume and response and In Vitro plating assay. Cancer Res 38: 2395–2400, 1978.PubMedGoogle Scholar
  63. 63.
    Hodges GM: An overview of tissue culture procedures in tumor biopsy studies. In: Human tumors in short term culture, Dendy PP (ed). New York: Academic Press, 1976, pp 3–14.Google Scholar
  64. 64.
    Ham RG: Unique requirements of clonal growth. J Natl Cancer Inst 53: 1459–1463, 1974.PubMedGoogle Scholar
  65. 65.
    Pretlow TG, Weiss EE, Zettergres JG: Problems connected with the separation of different kinds of cells. Int Rev Exp Pathol 14: 91–205, 1975.PubMedGoogle Scholar
  66. 66.
    Von Hoff DD, Casper J, Bradley E, Trent JM, Hodach A, Reichert C, Makuch R, Altman A: Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res 40:3591– 3597, 1980.Google Scholar
  67. 67.
    Mattox DE, Von Hoff DD: In Vitro stem cell assay in head and neck squamous carcinoma. Ann Surg 140: 527–530, 1980.CrossRefGoogle Scholar
  68. 68.
    Von Hoff DD, Weisenthal LM, Ihde DC, Mathews MJ, Layard M, Makuch R: Growth of lung cancer colonies from bronchial washings. Cancer 48: 400–403, 1981.CrossRefGoogle Scholar
  69. 69.
    Pollard EB, Tio F, Whitecar JP, Coltman CA, Jr, Von Hoff DD: Utilization of a soft agar system to monitor for marrow involvement with small cell carcinoma of the lung. Proc Am Assoc Cancer Res and ASCO 21: 192, 1980.Google Scholar
  70. 70.
    Salmon SE, Hamburger AW, Soehnlen BS, Durie BGM, Alberts DS, Moon TE: Quantitations of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321–1327, 1978.PubMedCrossRefGoogle Scholar
  71. 71.
    Salmon SE, Soehnlen BJ, Durie BGM, Alberts DS, Meyskens FL, Chen HSG, Moon TE: Clinical correlation of drug sensitivity in tumor stem cell assay. Proc Am Assoc Cancer Res and ASCO 20: 340, 1979.Google Scholar
  72. 72.
    Von Hoff DD, Casper J, Bradley E, Sandbach J, Jones D, Makuch R: Association between human tumor colony forming assay results and response of an individual patient’s tumor to chemotherapy. Am J Med 70: 1027–1032, 1981.CrossRefGoogle Scholar
  73. 73.
    Von Hoff DD, Page C, Harris G, Clark G, Cowan J, Coltman CA: Prospective clinical trial of a human tumor cloning system. Proc Am Assoc Cancer Res and ASCO 22: 154, 1981.Google Scholar
  74. 74.
    Alberts DS, Chen HSG, Young L, Moon TE, Leigh SA, Surwit EA, Salmon SE: Improved survival for relapsing ovarian cancer patients using the human tumor stem cell assay. Proc Am Assoc Cancer Res and ASCO 22: 462, 1981.Google Scholar
  75. 75.
    Von Hoff DD, Cowan JD, Harris G, Reisdorf G: Human tumor cloning: feasibility and clinical correlations. Cancer Chemother Pharmacol 6: 265–271, 1981.Google Scholar
  76. 76.
    Blum RH, Carter SK: Adriamycin: a new antitumor drug with significant clinical activity. Ann Intern Med 80: 249–259, 1974.PubMedGoogle Scholar
  77. 77.
    Salmon SE, Alberts D, Meyskens F, Durie B, Jones S, Soehnler B, Young L: A new concept: In Vitro trial with the human tumor stem cell assay (HTSCA). Proc Am Assoc Cancer Res and ASCO 21: 329, 1980.Google Scholar
  78. 78.
    Von Hoff DD, Rozencweig M, Muggia FM: Evaluation of cytotoxic drugs. Cancer Treat Rev 6: 1–8, 1979.CrossRefGoogle Scholar
  79. 79.
    Von Hoff DD, Rozencweig M, Soper W, Helman LJ, Davis HL, Penta JS, Muggia FM: Whatever happened to NSC “—”? An analysis of discontinued anticancer agents. Cancer Treat Rep 61: 759–768, 1977.Google Scholar
  80. 80.
    Von Hoff DD, Gutterman J, Portnoy B, Coltman CA: Human tumor cloning system as a bioassay for interferon. Cancer Chemother and Pharm (in press).Google Scholar
  81. 81.
    Cowan JD, Von Hoff DD: Use of a human tumor stem cell assay to screen retinoids for antineoplastic activity. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy 20: 29, 1980.Google Scholar
  82. 82.
    Cowan JD, Coltman CA, Jr, Von Hoff DD: Use of the human tumor cloning system to evaluate cytotoxic activity of misonidazole. Proc Am Assoc Cancer Res and ASCO 22: 233, 1981.Google Scholar
  83. 83.
    Von Hoff DD, Coltman CA, Jr, Forseth B: Activity of mitoxantrone in a human tumor cloning system: leads for phase II trials in man. Cancer Res 41: 1853–1855, 1981.Google Scholar
  84. 84.
    Von Hoff DD, Coltman CA, Jr, Forseth B: Activity of 9–10 anthracenedicarboxaldehyde bis (4,5-dihydro-IH-imidazol-2-yl)hydrozone) dihydrochloride (CL 216,942) in a human tumor cloning system: leads for phase II trials in man. Cancer Chemother and Pharm 6: 141–144, 1981.Google Scholar
  85. 85.
    Kern DH, Campbell MA, Worth GD, Morton DL: Cloning efficiencies and drug sensitivities of freshly prepared suspensions, cryopreserved cells and cell lines derived from human solid tumors. Proc Am Assoc Cancer Res and ASCO 22: 69, 1981.Google Scholar
  86. 86.
    Tannock I: Cell kinetics and chemotherapy: a critical review. Cancer Treat Rep 62:1117– 1133, 1978.Google Scholar
  87. 87.
    Silver RT, Young RC, Holland JF: Some new aspects of modern cancer chemotherapy. Am J Med 63: 772–787, 1977.PubMedCrossRefGoogle Scholar
  88. 88.
    Valeriote FA, Edelstein MB: The role of cell kinetics in cancer chemotherapy. Semin Oncol 4: 217–226, 1977.PubMedGoogle Scholar
  89. 89.
    Shackney SE, McCormack GW, Cuchural GJ: Growth rate patterns of solid tumors and their relation to responsiveness to therapy. Ann Int Med 89: 107–121, 1978.PubMedGoogle Scholar
  90. 90.
    Elson DL, Livingston RB, Coltman CA, Jr, Von Hoff DD: Labeling index depression in human tumor cells cultured in double-layer agar: a potential chemosensitivity assay. Proc Am Assoc Cancer Res and ASCO 21: 164, 1980.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1983

Authors and Affiliations

  • John D. Cowan
  • Daniel D. Von Hoff

There are no affiliations available

Personalised recommendations